Project to build German EV microchip factory put on hold
Putin calls for alternative international payment system at Brics summit
Norway to increase minimum age limit on social media to 15 to protect children
What does Elon Musk want from all this politicking?
Rupert Murdoch’s Dow Jones and New York Post sue AI firm for ‘illegal copying’
Less regulation of weight-loss drug would make Wegovy accessible to more people
Ministers are launching a £40m pilot scheme to trial wider access to the controversial slimming jab Wegovy, to examine how people could receive the drug outside hospitals.
Under current advice from the National Institute for Health and Care Excellence drugs regulator, Wegovy is only given via specialist weight management services, usually based in hospitals.
More Stories
Sweden warns of heightened risk of Russian sabotage
NHS in England to trial AI tool to predict risk of fatal heart disease
Rise of almost untreatable superbug linked to a common antibiotic